Acne Spot and Area Treatment
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Soufre Source : Soufre | 5 Pour cent |
Non-medicinal ingredients
Méthylpropanediol, Jus de feuilles d'Aloe Barbadensis, L-arginine, Sel de magnésium de monophosphate d'ascorbyle, Aqua, Chlorphénésine, Butylène glycol, Extrait d'écorce de Morus alba, Triéthoxycaprylylsilane, Extrait de pépins de Vitis Vinifera (raisin), Dioxyde de titane, Cétéareth-20, Acétate de dl-alpha tocophéryle, Myristate d'isopropyle, Acide myristique, Rosinate de méthyle, Acide glycolique, Extrait d'écorce de Salix Alba (Saule blanc), Poly(acrylamide), EDTA de sodium, Acide sorbique, Dipropylène glycol, Bitartrate de potassium, Amidon de Zea Mays (maïs), Benzoate de sodium, Zéolite, Allantoïne, Hexylène Glycol, Extrait de fleur/feuille/tige d'Epilobium Angustifolium, Filtrat de fermentation de racine de radis par la bactérie Leuconostoc, Extrait de racine de Glycyrrhiza Glabra (Réglisse), Oxyde de zinc, Bisabolol, Extrait de feuilles d'Arctostaphylos Uva Ursi, Poly(dipropylèneglycol adipate), Stéarate de PEG-100, Sorbate de potassium, Laureth-7, Isoparaffine en C13 à 14, Terpinéol, Métabisulfite de sodium, Caprylyl glycol, Acide salicylique, Acide caprylhydroxamique, Lécithine hydrogénée, Phénoxyéthanol, Silicate de magnésium et d'aluminium, Citrate de triéthyle, Acide benzoïque, Méthyle de rosinate hydrogéné, Extrait de fruit de Citrum Aurantium Dulcis (Oranger), Acétate de menthyle, Myristate de 2-octyldodécyle, Benzoate de potassium, 4-Terpinéol, 2,6-Diméthyl-7-octen-2-ol, Extrait de Fleur/Feuilles/Tige de Lavandula Angustifolia (Lavande), Acide citrique, Menthol, Glycérine, Gomme Arabique du Sénégal, Glycyrrhizate de dipotassium, DL-Panthénol, Extrait d'Echinacea angustifolia, Hydroxyde de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | Not specified | Not specified |
Uses authorised in Canada
For the treatment/management of acne.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Sensitivity Test for a New User: Apply product sparingly to one or two small affected areas during the first three days. If no discomfort occurs, follow the directions on this label. Warnings: Use only as directed. For external use only. Avoid contact with eyes; if contact occurs, rinse thoroughly with water. If swallowed, call a Poison Control Centre or a health care professional immediately. When using this product, skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time unless directed by a health care professional. Apply only to areas with acne. Do not use on broken skin or on large areas of the skin. Discontinue use if excessive skin irritation develops or increases. If irritation persists or spreads beyond the site of application, and/or if substantial improvement is not apparent within 6-8 weeks, consult a health care professional. This product contains an alpha hydroxy acid (AHA) that may increase skin sensitivity to the sun and the possibility of sunburn. Prior to sun exposure, apply sunscreen to areas where this product has been used. Contact of the product with the skin must be of limited frequency or duration. This product may cause irritation, burning, itching, swelling and blistering of the skin. If this occurs, discontinue use. If you develop severe itching, hives, swelling of eyes and mouth, blistering or difficulty breathing, consult a health care professional.
Product record
- Licence holder
- Peter Thomas Roth Labs LLC
- NPN or DIN-HM
- 80076403
- Status
- Inactive licence
- Licence date
- 28 March 2017
- Revision date
- 6 September 2018
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
Source
Official Health Canada record, licence 80076403
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Acne Spot and Area Treatment”, https://compoatlas.com/en/supplements/canada/80076403-acne-spot-and-area-treatment, updated 6 September 2018.